High resolution nerve ultrasound in neurofibromatosis type 1: a prospective and descriptive study
Year: 2025
Type: article
Study design: Observational Study
Abstract: Objective To explore the value of high resolution nerve ultrasound (HRUS) 3 and nerve conduction studies (NCS) 4 in screening for plexiform neurofibromas (PNs) 5 in neurofibromatosis type 1 (NF1). 6 Methods Adult patients with NF1 were eligible. Patients were divided into two groups: with peripheral nervous system related symptoms (PNS 7 group) and without PNS-related symptoms (non-PNS group). Study visit included neurological examination, NCS and HRUS. Results Sixty patients were enrolled, 37 in the PNS group and 23 in the non-PNS group. HRUS was abnormal in 52 patients (87 %), 34 in the PNS group (92 %) and 18 in the non-PNS group (78 %, p = 0.24). Patients with continuous nerve enlargements (high PN tumor load) were easily distinguished with HRUS. 85 % of patients with normal NCS have nerve enlargements on HRUS. Conclusions HRUS helps to assess PN tumor burden in NF1. NCS did not have additional value. Significance HRUS might be useful as a screening tool for PN in NF1, especially in settings with less MRI availability.
Source: Clinical Neurophysiology
Authors: D. Christine Noordhoek, Tessa A. Ennik, Sarah A. van Dijk, Eline Mann, Sophie van der Vlist, Judith Drenthen, Walter Taal
Institutions: Erasmus MC Cancer Institute, Erasmus MC
Language: English
Subfield: Neurology
Field: Medicine
Domain: Health Sciences
Open Access status: hybrid
Estimated APC paid: $3,790
OpenAlex ID: W4413624271
